Back to search

Article

Comparative Meta-Analysis of Four Breakthrough Medical Innovations (2015–2025): CRISPR, mRNA Vaccines, AI Diagnostics, and Telemedicine

2025-06-27

Abstract excerpt

<title>Abstract</title> <p>We performed a comprehensive meta-analysis of four major medical innovations (2015–2025) CRISPR gene editing, mRNA vaccines, AI diagnostics, and telemedicine focusing on clinical efficacy, health outcomes, and adoption. For CRISPR therapies in hemoglobinopathies, pooled data from six trials (115 patients) show robust clinical benefits: significant fetal hemoglobin induction, transfusion...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
efc5a480-6331-5c20-b978-af4dd9a50d62
DOI
10.21203/rs.3.rs-6977013/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparative Meta-Analysis of Four Breakthrough Medical Innovations (2015–2025): CRISPR, mRNA Vaccines, AI Diagnostics, and TelemedicineDOI 10.21203/rs.3.rs-6977013/v1
Towards affordable CRISPR genomic therapies: a task force convened by the Innovative Genomics InstituteSemantic proximity
Public Knowledge, Attitudes, and Ethical Views on CRISPR-Cas 9 in Taif, Saudi ArabiaSemantic proximity
The Italian breakthrough in CRISPR trials for rare diseases: a focus on beta-thalassemia and sickle cell disease treatmentSemantic proximity
The dawn of a cure for sickle cell disease through CRISPR‐based treatment: A critical test of equity in public health genomicsSemantic proximity
Using Clustered Regularly Interspaced Short Palindromic Repeats gene editing to induce permanent expression of fetal hemoglobin in β-thalassemia and sickle cell disease: A comparative meta-analysisSemantic proximity
CRISPR in Public Health: The Health Equity Implications and Role of Community in Gene-Editing Research and ApplicationsSemantic proximity
The N=1 Collaborative: advancing customized nucleic acid therapies through collaboration and data sharingSemantic proximity
Clinical genetic counselor experience in the adoption of telehealth in the United States and Canada during the COVID‐19 pandemicSemantic proximity
Regulatory insights on advanced CAR-T cell products, AAV-based Gene therapies, and medical care/practice in cell and Gene therapies: Report from the 6th Asia partnership conference of regenerative medicine- April 20, 2023Semantic proximity
A CRISPR focus on attitudes and beliefs toward somatic genome editing from stakeholders within the sickle cell disease communitySemantic proximity
Integrative Multiomic Analysis Reveals How Non-Viral Delivery System Selection Shapes CRISPR Gene Editing Outcomes in Stem CellsSemantic proximity
Safety and Efficacy of CTX001 in Patients with Transfusion-Dependent β-Thalassemia and Sickle Cell Disease: Early Results from the Climb THAL-111 and Climb SCD-121 Studies of Autologous CRISPR-CAS9-Modified CD34+ Hematopoietic Stem and Progenitor CellsSemantic proximity
Select a neighboring publication to make it the new centre.